343 related articles for article (PubMed ID: 17826528)
21. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
22. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
[TBL] [Abstract][Full Text] [Related]
23. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
24. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
25. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
26. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Ménière's disease by intratympanic gentamicin application.
Assimakopoulos D; Patrikakos G
J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
[TBL] [Abstract][Full Text] [Related]
28. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
29. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
Helling K; Schönfeld U; Clarke AH
Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
[TBL] [Abstract][Full Text] [Related]
31. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
Suryanarayanan R; Srinivasan VR; O'Sullivan G
J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
33. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
Carey J
Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
[TBL] [Abstract][Full Text] [Related]
34. Menière's disease and gentamicin: preliminary results using the minimum effective dose and integrated therapy.
Sala T
Acta Otorhinolaryngol Ital; 2003 Apr; 23(2):78-87. PubMed ID: 14526554
[TBL] [Abstract][Full Text] [Related]
35. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
36. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
Atlas JT; Parnes LS
Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
[TBL] [Abstract][Full Text] [Related]
37. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
Büki B; Platz M; Haslwanter T; Jünger H; Avan P
Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
[TBL] [Abstract][Full Text] [Related]
38. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
Longridge NS; Mallinson AI
J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
[TBL] [Abstract][Full Text] [Related]
39. [Intratympanic gentamycin in association with human fibrin glue in the treatment of Meniere's disease: preliminary results].
Casani AP; Dallan I; Sellari-Franceschini S; Nuti D
Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):199-207. PubMed ID: 12379040
[TBL] [Abstract][Full Text] [Related]
40. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
Perez N; Rama-Lopez J
J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
